Letters to the Editor
Mike Barr and Rob Camp -- The article on the HIV Web sites and how their sponsors might influence their reporting is groundbreaking. TAG could do a great Sunday New York Times Magazine piece using these tables as the essential…
Truvánadu: Does Gilead’s Famed 903 Study Really Show You What They Tell You It Shows?
Does Gilead's Famed 903 Study Really Show You What They Tell You It Shows? By Steven Miles, M.D. Betting on Holy Water "Tenofovir/FTC Is Superior to Combivir!!" Is this really believable? Or how about "AZT/3TC equals ABC/3TC"?? Of course not.…
Cell Therapy aka Therapeutic “Vaccine” Surprise Announcement for World AIDS Day
By Mike Barr Even the researchers admit any definitive conclusions must await more rigorous investigation. But on the eve of World AIDS Day the news of a possible novel, less onerous, and much more affordable approach to the treatment of…
Project Inform’s IX IRTT: Why the Tap ‘n’ Drainers Have Always Been Wrong; Plus, a New Theory About MDR HIV
Why the Tap 'n' Drainers Have Always Been Wrong; Plus, a New Theory About MDR HIV By Richard Jefferys The Primacy of Immune Activation Project Inform, the country's longest serving community-based AIDS treatment information organization, has been sponsoring scientific think…
Treble Damages: Vaccine Scientists Struggle to Come to Grips With the Field’s “Berlin”
Vaccine Scientists Struggle to Come to Grips With the Field's "Berlin" By Richard Jefferys Technologically Challenged? The AIDS Vaccines 2004 Conference was held from August 30-September 1 in Lausanne, Switzerland, the first of these meetings to be held outside the…
Little Leap: Gilead 2-in-1 Opens Door to Impending One-Pill Triple Combo
Gilead 2-in-1 Opens Door to Impending One-Pill Triple Combo By Rob Camp GSK's, a Sort of Snoozer In early August the FDA announced the approvals of two fixed-dose combination (FDC) antiretroviral drug products. FDCs are combinations of two previously approved…
A Call to Arms: Veteran NEJM Editor Takes on Big Pharma as No One Before; Calls for Sweeping Reforms
Veteran NEJM Editor Takes on Big Pharma as No One Before; Calls for Sweeping Reforms Party Pooper "I find it hard to imagine that a system this corrupt can be a good thing, or that it is worth the…
The Agony of Bangkok: Thai Activist Exhorts Conference Crowd to Stand Firm Against U.S. Patent Regime and “Masks of Fake Concern”
Thai Activist Exhorts Conference Crowd to Stand Firm Against U.S. Patent Regime and "Masks of Fake Concern" By Paisan Suwannawong "Trading Away Health" The following is the text of an address delivered by Thai AIDS Treatment Action Group director Paisan…
The Irony of Bangkok: How to Get 6 Million Poor People on Antiretroviral Therapy — and 1 Million Rich People Off
How to Get 6 Million Poor People on Antiretroviral Therapy -- and 1 Million Rich People Off In a brief July editorial, "Freedom of Choice," UK-based AIDS Treatment Update editor Edwin Bernard captures the essence of the present day therapeutic…
TDM, Stat! More Mixes Nixed By Concentration Preoccupations
More Mixes Nixed By Concentration Preoccupations By Yasmin Halima and Rob Camp Statin Strength Relative Potency of the HMG-CoA Reductase Inhibitors (a.k.a. Statins) Drug Daily Dose Relative Potency* Fluvastatin (Lescol) 60 mg 1 Pravastatin (Pravachol) 60 mg 2 Lovastatin (Mevacor) 20 mg 3…